DISTAL CHOLANGIOCARCINOMA
Clinical trials for DISTAL CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new DISTAL CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for DISTAL CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pancreas cancer surgery showdown: total removal may boost survival
Disease control Recruiting nowThis study looks at whether removing the entire pancreas is better than removing just part of it for people with certain cancers in the head of the pancreas who are at high risk of complications. The main goal is to see if total removal helps patients live longer without hurting …
Matched conditions: DISTAL CHOLANGIOCARCINOMA
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a smaller incision offer the same cancer surgery outcome?
Disease control Recruiting nowThis trial compares two surgical techniques for removing tumors near the pancreas (non-pancreatic periampullary adenocarcinomas). One method uses a single small incision plus one extra port, while the other uses the conventional five-port approach. The study will enroll 232 adult…
Matched conditions: DISTAL CHOLANGIOCARCINOMA
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Personalized cancer care: new trial aims to improve outcomes in biliary cancer
Disease control Recruiting nowThis phase 3 trial is testing whether giving a targeted therapy after initial standard chemotherapy can help people with advanced biliary cancer live longer without their disease getting worse. Participants must have a tumor with a specific genetic change and stable disease after…
Matched conditions: DISTAL CHOLANGIOCARCINOMA
Phase: PHASE3 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for bile duct cancer: experimental drug takes on chemo
Disease control Recruiting nowThis study tests a new drug called ivonescimab against standard chemotherapy (FOLFOX) for people with advanced bile duct cancer that has worsened after initial treatment. About 72 participants who were in the SAFIR-ABC10 trial will be randomly assigned to receive either ivonescim…
Matched conditions: DISTAL CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Keyhole surgery vs. open surgery for pancreatic cancer: which is safer?
Disease control Recruiting nowThis study compares two types of Whipple surgery for people with pancreatic or nearby cancers: the traditional open surgery and a newer keyhole (laparoscopic) approach. About 90 adults with resectable tumors will be randomly assigned to one of the two procedures. The goal is to s…
Matched conditions: DISTAL CHOLANGIOCARCINOMA
Phase: NA • Sponsor: Minia University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Can blood tests reveal how liver and bile duct cancers respond to treatment?
Knowledge-focused Recruiting nowThis study follows 150 adults with liver or bile duct cancer who are receiving standard treatments like surgery, ablation, or chemotherapy. Researchers will collect repeated blood samples before, during, and after treatment to analyze tumor DNA, immune cells, and proteins. The go…
Matched conditions: DISTAL CHOLANGIOCARCINOMA
Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC